Disease advancements focus of Delaware conference

Researchers to share Ebola advancements information
Researchers to share Ebola advancements information | Courtesy of

The New Technologies, New Vaccines Conference will bring more than 100 scientists, regulatory agency members and business leaders from across the globe to Wilmington, Delaware, March 22-25.

Participants will share information on advancements made in the fight against such deadly diseases as chikungunya, dengue, Ebola, influenza and HIV. They also will share information about preventing and treating cancer, HIV and the herpes simplex virus as well as advancements in producing and expressing proteins with new technologies.

Kathryn Zoon, director of the Division of Intramural Research at the National Institute of Allergies and Infectious Diseases, will be the featured speaker at the conference. She will present information about the stages and challenges of vaccine development.

The conference is being presented by the Fraunhofer USA Center for Molecular Biotechnology in cooperation with the International Association for Biological Standardization.

“With the growing global demand for vaccines and other biologics, the need for new high-performance technologies for vaccine identification, design, development and manufacturing is critical,” Dr. Vidadi Yusibov, executive director of Fraunhofer USA CMB, said.
“During the conference, we will share new knowledge and facilitate discussions and potential collaborations among representatives from academic research, government and industry fostering additional discoveries and development of new tools for effective prevention of global epidemic threats."

Organizations in this Story

Fraunhofer USA Center for Molecular Biotechnology National Institute of Allergy and Infectious Diseases (NIAID)

Want to get notified whenever we write about any of these organizations ?
Next time we write about any of these organizations, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.